A recent survival analysis of patients with stage I-III GC in the SEER database did not show clinically relevant survival differences between so-called mucin-producing (N = 1515) and conventional adenocarcinomas (N = 4174), either when they were treated with surgery only or chemotherapy. Here, MUC5AC is linked to adenocarcinoma.